Steroids help with some forms of vertigo, but the benefit depends heavily on what is causing the vertigo, how the steroids are given, and how quickly treatment begins. For vestibular neuritis, the most studied use case, corticosteroids roughly double the odds of restoring inner-ear function in the short term, though long-term advantages are less clear. For Ménière’s disease, steroid injections through the eardrum can quiet vertigo attacks in a majority of patients. For other causes of vertigo, like benign positional vertigo (BPPV), steroids do almost nothing. The picture is more nuanced than a simple yes or no, and the details matter for anyone facing a vertigo diagnosis.
Vestibular Neuritis and the Case for Steroids
Vestibular neuritis is an inflammation of the nerve that carries balance signals from the inner ear to the brain. It typically strikes suddenly, causing intense spinning vertigo that lasts days and can take weeks or months to fully resolve. Because inflammation is the core problem, corticosteroids are a logical treatment, and they are the most studied steroid use in vertigo. An updated meta-analysis found that steroid-treated patients had about 2.4 times the odds of recovering normal vestibular function compared with control groups.1PubMed. Corticosteroids in patients with vestibular neuritis: An updated meta-analysis A review of treatment approaches confirmed that corticosteroids improve recovery from acute vestibular neuritis based on controlled and uncontrolled studies.2PubMed Central. The treatment and natural course of peripheral and central vertigo
That said, the evidence carries some serious caveats. The studies pooled in the meta-analysis varied widely in design and quality, and the confidence intervals were broad enough that researchers themselves cautioned only “a careful judgement of some benefit.”1PubMed. Corticosteroids in patients with vestibular neuritis: An updated meta-analysis A Cochrane systematic review of four trials involving 149 patients found that steroids significantly improved caloric test recovery at one month but showed no significant effect at twelve months. And when it came to what patients actually feel, including dizziness handicap scores and vertigo at 24 hours, steroids did not outperform placebo at any time point measured.3PubMed Central. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) In practical terms, steroids seem to accelerate how quickly the vestibular nerve bounces back on objective tests, but they have not convincingly been shown to make patients feel better faster or to change outcomes a year down the line.
Why Timing Makes a Big Difference
One of the clearest findings in the vestibular neuritis literature is that earlier steroid treatment works better. A study that stratified patients by how soon they started steroids found a striking gap: every patient treated within 24 hours of symptom onset had normal caloric test results at three-month follow-up, compared with only about 58 percent of those who started treatment between 25 and 72 hours.4PubMed Central. Steroids for Acute Vestibular Neuronitis—the Earlier the Treatment, the Better the Outcome? The researchers described this as a “critical time slot” for steroid effectiveness.
This matters practically because vestibular neuritis often sends people to the emergency room with severe spinning, nausea, and vomiting. If steroids are going to be prescribed, the evidence suggests that starting them in the first day makes the most difference. Waiting several days to see a specialist and then beginning a course of oral steroids misses the window where the strongest benefit has been observed. An early controlled trial of methylprednisolone found that nine out of ten patients on the steroid had marked symptom reduction, while only three of ten on placebo improved. The seven placebo patients who still had symptoms were switched to methylprednisolone and all responded within 24 hours.5JAMA Otolaryngology–Head & Neck Surgery. The Beneficial Effect of Methylprednisolone in Acute Vestibular Vertigo
Ménière’s Disease and Intratympanic Steroids
Ménière’s disease is a different beast from vestibular neuritis. Rather than a one-time inflammatory event, it involves recurring episodes of vertigo, hearing loss, tinnitus, and a feeling of fullness in the ear, linked to excess fluid in the inner ear. Steroids enter the picture here too, but via a different route: injected directly through the eardrum into the middle ear, a procedure called intratympanic injection.
This approach can work well for vertigo control. A mini-review of intratympanic steroid studies found that the median rate of complete vertigo control at two years was about 72 percent, with repeated “as-needed” injection protocols tending to do better than a single treatment.6PubMed Central. Intratympanic corticosteroids in Ménière’s disease: A mini-review A quality-of-life study found improvement in about 73 percent of patients, particularly in the emotional and physical domains, with most patients reporting less vertigo and instability after treatment.7PubMed Central. Quality of life after intratympanic steroid injection for Ménière’s disease The same study noted that hearing, tinnitus, and ear fullness did not change much, which is a useful expectation to set: intratympanic steroids in Ménière’s are primarily a vertigo treatment, not a hearing treatment.
Not everyone responds equally. One study found that about 56 percent of patients had satisfactory vertigo control for a full year after their first round of injections, while the remaining 44 percent needed alternative treatment.8PubMed. Differences in responsiveness of intratympanic steroid injection for intractable vertigo in Meniere’s disease This roughly matches the broader pattern: intratympanic steroids help a majority of Ménière’s patients with vertigo, but a substantial minority does not respond and needs to move on to other options such as micropressure therapy or, in severe cases, surgical interventions.
Oral steroids have also been tried for Ménière’s. A pilot study of oral prednisone in patients whose vertigo had resisted other treatments found that it cut the frequency of vertigo episodes by about half and their duration by about 30 percent.9PubMed. Oral administration of prednisone to control refractory vertigo in Ménière’s disease: a pilot study Oral steroids are generally considered a short-term bridge or a way to test whether a patient’s disease is steroid-responsive before committing to repeated injections, because long courses of oral steroids carry substantial systemic side effects.
Why Intratympanic Delivery Beats Pills for the Inner Ear
The inner ear is a surprisingly hard organ to reach with medication. It sits behind the blood-labyrinth barrier, which is similar in concept to the blood-brain barrier and limits how much of an oral or intravenous drug actually gets into the cochlear and vestibular fluids. Intratympanic injection sidesteps this problem by placing the drug directly on the round window membrane, where it diffuses into the inner ear.
The concentration difference is dramatic. In guinea pigs, intratympanic dexamethasone produced inner-ear drug levels roughly 88 times higher than an equivalent intravenous dose, and after adjusting for the actual dosage difference, the local route achieved about 260 times the concentration.10PubMed. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph Another study confirmed that intratympanic delivery produced higher drug levels in the inner ear’s sensory structures than systemic dosing, though it also found that the distribution pattern differs: systemic steroids actually reach higher concentrations in one particular structure, the stria vascularis, which maintains the electrochemical environment of the inner ear.11PubMed. A comparison of systemic and local dexamethasone administration: From perilymph/cochlea concentration to cochlear distribution
This distribution difference is part of why the two routes are sometimes used for different conditions, or even combined. For vestibular neuritis, where the inflammation is on the nerve itself and systemic steroids can reach it through the bloodstream, oral treatment is standard. For Ménière’s disease, where the target is the fluid dynamics within the inner ear, intratympanic injections deliver far more drug to the right spot with far fewer systemic side effects. An animal study found that even high-dose intratympanic dexamethasone did not damage hearing or vestibular function and caused no visible harm to the inner or middle ear tissue, with the drug still detectable two months after injection.12PubMed. Nongenomic effects of corticosteroids on ion transport by stria vascularis
What Steroids Actually Do Inside the Inner Ear
Corticosteroids are well known for reducing inflammation, but their effects in the inner ear go beyond just calming swelling. One mechanism involves how the inner ear maintains its unusual fluid chemistry. The cochlea contains endolymph, a fluid with an unusually high potassium concentration that is essential for hearing and balance. The stria vascularis, a tissue lining part of the cochlea, actively pumps potassium into this fluid. Research on isolated stria vascularis tissue showed that prednisolone increased potassium secretion through a rapid, nongenomic mechanism, meaning the steroid acted within seconds rather than through the hours-long process of altering gene expression.12PubMed. Nongenomic effects of corticosteroids on ion transport by stria vascularis Hydrocortisone and dexamethasone had a similar but shorter-lived effect, while aldosterone, a different class of steroid hormone, actually reduced potassium transport.
This means corticosteroids may help the inner ear in at least two ways: the classical anti-inflammatory pathway, which reduces nerve swelling in conditions like vestibular neuritis, and a faster ion-transport effect that may help restore or stabilize the fluid balance disrupted in conditions like Ménière’s. The dual mechanism helps explain why steroids show up as a treatment across several different inner-ear disorders despite those disorders having quite different underlying causes.
Autoimmune Inner Ear Disease
In autoimmune inner ear disease (AIED), the immune system attacks the inner ear, typically causing progressive hearing loss and sometimes vertigo. This is the condition where steroids play the most central role. Corticosteroids are the cornerstone of AIED therapy: patients typically receive a month-long course of oral prednisone, and if hearing improves, the dose is slowly tapered over six to twelve months while hearing is monitored at each step.13Journal of Clinical Investigation. IL-1β inhibition in autoimmune inner ear disease: can you hear me now?
The response rate is meaningful but not overwhelming. One study of 39 patients treated with immunosuppressive therapy found that about 59 percent showed a positive response. Patients who responded to steroids alone tended to see greater hearing improvement, while those who needed additional cytotoxic drugs showed better gains in word recognition scores.14Ear, Nose & Throat Journal. Autoimmune Inner Ear Disease: Steroid and Cytotoxic Drug Therapy A separate study found a similar initial steroid response rate of about 60 percent, with some steroid-dependent patients eventually able to taper off prednisone by switching to targeted biologic therapies.15PubMed Central. Autoimmune inner ear disease: A systematic review of management
The challenge with AIED is that many patients become steroid-dependent, meaning their symptoms return every time the dose drops below a certain threshold. Long-term oral prednisone carries well-known risks including weight gain, bone thinning, blood sugar elevation, mood changes, and increased infection susceptibility. Finding steroid-sparing alternatives is an active area of research, though steroids remain the first-line treatment because nothing else has a comparable track record in this disease.
Steroids Versus Vestibular Rehabilitation
Vestibular rehabilitation therapy (VRT) involves structured exercises that help the brain recalibrate its balance processing after inner-ear damage. It is a standard treatment for vestibular neuritis, and a natural question is whether steroids or exercises work better, or whether combining them adds value.
A randomized clinical trial comparing corticosteroids alone to vestibular exercises alone for vestibular neuritis found that both groups improved similarly. Dizziness handicap scores and clinical recovery measures showed no statistically significant difference between the two approaches at one month or at twelve months. Patients doing vestibular exercises showed a trend toward slightly greater improvement in dizziness scores over the full year, but the gap was not large enough to be statistically meaningful.16JAMA Otolaryngology–Head & Neck Surgery. Corticosteroids and Vestibular Exercises in Vestibular Neuritis: Single-blind Randomized Clinical Trial
What about doing both? A systematic review and meta-analysis of randomized trials found that combining steroids with vestibular rehabilitation produced lower dizziness scores than steroids alone at three months. However, by twelve months, there was no significant difference between any of the groups, whether treated with steroids alone, exercises alone, or the combination.17PubMed Central. Vestibular Rehabilitation Therapy and Corticosteroids for Vestibular Neuritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials The pattern suggests that the combination speeds up early recovery, but the brain’s own compensatory mechanisms eventually catch up regardless of treatment approach. This is consistent with the Cochrane review’s finding that steroids do not change outcomes at one year.
In clinical practice, many patients with vestibular neuritis receive both: a short course of steroids in the acute phase to reduce nerve inflammation, followed by vestibular rehabilitation exercises once the worst of the spinning has passed. The rationale is that steroids address the initial damage while exercises help the brain adapt to whatever deficit remains.
When Steroids Do Not Help Vertigo
The most common cause of vertigo is BPPV, which accounts for roughly a quarter of all vertigo cases. BPPV happens when tiny calcium carbonate crystals break loose in the inner ear and drift into the semicircular canals, where they do not belong. This is a mechanical problem, not an inflammatory one, and steroids have no role in treating it. The standard treatment is repositioning maneuvers, like the Epley maneuver, which physically guide the crystals back to where they cause no trouble.
Central causes of vertigo, meaning problems in the brain itself rather than the inner ear, are generally not steroid-responsive either, unless a specific inflammatory or autoimmune process is at work (like multiple sclerosis, where steroids may be used during a flare). Migrainous vertigo (vestibular migraine), another increasingly recognized cause of recurrent vertigo episodes, is managed with migraine-specific treatments, not corticosteroids.
This is worth emphasizing because “vertigo” is a symptom, not a diagnosis. Whether steroids will help depends entirely on what is causing it. Prescribing steroids for vertigo without first identifying the underlying condition would be like prescribing antibiotics for a cough without knowing whether it is caused by bacteria. The diagnostic workup, which typically involves balance testing, hearing tests, and sometimes imaging, determines whether steroids are appropriate.
Ramsay Hunt Syndrome
Ramsay Hunt syndrome occurs when the varicella-zoster virus (the same virus that causes chickenpox and shingles) reactivates in the nerve near the inner ear, causing facial paralysis, ear pain, and often vertigo. Treatment usually involves antiviral drugs combined with corticosteroids. A systematic review and meta-analysis looked at whether adding antivirals to steroids improved outcomes and found no statistically significant benefit from the antiviral component alone or the combination over steroids alone.18PubMed. Antiviral treatment for Ramsay Hunt syndrome: A systematic review and meta-analysis This has not changed standard practice, where combination therapy is still typically used, but it highlights that the steroid component may be doing most of the heavy lifting for this condition.
Children and Vertigo
Vertigo in children is rarer and less well studied than in adults. Vestibular neuritis does occur in children and adolescents, but the evidence base for steroid treatment in this age group is extremely thin. One study of pediatric vestibular neuritis cases noted that only two patients received oral steroids, and neither had incomplete recovery, but the numbers are far too small to draw conclusions.19PubMed. Vestibular neuritis in children and adolescents: Clinical features and recovery The researchers themselves stated that treatment of pediatric vestibular neuritis with steroids deserves further study. In practice, clinicians often extrapolate from adult data when treating children, but this is an area where the evidence genuinely does not exist yet, and treatment decisions involve more clinical judgment and less guideline-following than in adults.
Practical Side-Effect Considerations
The side-effect profile of steroids for vertigo depends almost entirely on how they are given and for how long. A short oral course, the kind typically used for vestibular neuritis (a week or two of tapering doses), carries relatively mild risks: insomnia, appetite increase, mood changes, and a temporary bump in blood sugar that matters mainly for people with diabetes. These are usually tolerable and resolve when the drug is stopped.
Intratympanic injections largely avoid systemic side effects because the drug stays local. The main risks are discomfort during the injection, a temporary feeling of fullness or dizziness right after the procedure, and a small risk of eardrum perforation. Some patients experience a temporary change in taste from the anesthetic used to numb the eardrum. Compared with the alternative intratympanic treatment for Ménière’s, gentamicin injection, which deliberately destroys vestibular hair cells to stop vertigo signals, steroid injections are considered the gentler option because they do not carry the risk of worsening hearing loss or permanently damaging balance function.
Long-term oral steroid use, as sometimes required in autoimmune inner ear disease, is a different situation. Months of prednisone can cause significant weight gain, elevated blood pressure, cataracts, osteoporosis, and immune suppression. This is why the treatment protocol for AIED involves careful tapering and why researchers are actively looking for steroid-sparing alternatives. The side effects of long-term steroids are well documented across many medical fields, and they apply just as much when the reason for taking them happens to be an inner-ear condition.